Your search returned 719 results.

Results
	261.	Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutations. [electronic resource] by Haaland, Benjamin Tan, Pui San de Castro, Gilberto Lopes, Gilberto Producer: 20150130 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	262.	Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy. [electronic resource] by Felip, Enriqueta Hirsh, Vera Popat, Sanjay Cobo, Manuel Fülöp, Andrea Dayen, Charles Trigo, José M Gregg, Richard Waller, Cornelius F Soria, Jean-Charles Goss, Glenwood D Gordon, James Wang, Bushi Palmer, Michael Ehrnrooth, Eva Gadgeel, Shirish M Producer: 20190408 In: Clinical lung cancer vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	263.	A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors. [electronic resource] by Marshall, John Hwang, Jimmy Eskens, Ferry A L M Burger, Herman Malik, Shakun Uttenreuther-Fischer, Martina Stopfer, Peter Ould-Kaci, Mahmoud Cohen, Roger B Lewis, Nancy L Producer: 20130924 In: Investigational new drugs vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	264.	Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells. [electronic resource] by Ioannou, Nikolaos Seddon, Alan M Dalgleish, Angus Mackintosh, David Modjtahedi, Helmout Producer: 20130828 In: BMC cancer vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	265.	Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review . [electronic resource] by Hann, Alexander Nosalski, Evelyn Hermann, Patrick C Egger, Jan Seufferlein, Thomas Keller, Frieder Producer: 20181018 In: Clinical nephrology vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	266.	Chronic myelomonocytic leukemia blast crisis in a patient with advanced non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors. [electronic resource] by Ogata, Hiroaki Okamoto, Isamu Yoshimoto, Goichi Obara, Teppei Ijichi, Kayo Iwama, Eiji Harada, Taishi Akashi, Koichi Nakanishi, Yoichi Producer: 20170919 In: Respiratory investigation vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	267.	Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung. [electronic resource] by Hsu, Jui-Feng Lee, Yen-Lung Chang, Hsu-Liang Wei, Po-Ju Shen, Yu-Ting Lin, Chi-Min Li, Ching-Yi Chong, Inn-Wen Yang, Chih-Jen Producer: 20191203 In: Asia-Pacific journal of clinical oncology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	268.	Effects of the [electronic resource] by Tan, Yanan Cao, Kangna Ren, Guanghui Qin, Zhiying Zhao, Di Li, Ning Chen, Xijing Xia, Yufeng Lu, Yang Producer: 20200313 In: Xenobiotica; the fate of foreign compounds in biological systems vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	269.	Structural analysis of the EGFR TK domain and potential implications for EGFR targeted therapy. [electronic resource] by Nie, Weiwei Tang, Lin Zhang, Haiyang Shao, Jiaqing Wang, Yucai Chen, Longbang Li, Donghai Guan, Xiaoxiang Producer: 20120730 In: International journal of oncology vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	270.	Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors. [electronic resource] by Furuyama, Kazuto Harada, Taishi Iwama, Eiji Shiraishi, Yoshimasa Okamura, Kyoko Ijichi, Kayo Fujii, Akiko Ota, Keiichi Wang, Shuo Li, Heyan Takayama, Koichi Giaccone, Giuseppe Nakanishi, Yoichi Producer: 20130913 In: Cancer science vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	271.	Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs. [electronic resource] by Brückl, Wolfgang Tufman, Amanda Huber, Rudolf Maria Producer: 20170529 In: Expert review of anticancer therapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	272.	Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187. [electronic resource] by Dömötör, Orsolya Pelivan, Karla Borics, Attila Keppler, Bernhard K Kowol, Christian R Enyedy, Éva A Producer: 20180917 In: Journal of pharmaceutical and biomedical analysis vol. 154 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	273.	Successful Treatment of Lung Adenocarcinoma with Epidermal Growth Factor Receptor Compound Mutations Involving Exon 19 Deletion and Exon 20 Insertion by Afatinib. [electronic resource] by Ikeuchi, Tomoyuki Tokuyasu, Hirokazu Ishikawa, Soichiro Producer: 20190215 In: Internal medicine (Tokyo, Japan) vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	274.	Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada. [electronic resource] by Ezeife, Doreen A Kirk, Veronica Chew, Derek S Nixon, Nancy A Lee, Roy Le, Lisa W Chan, Kelvin K-W Leighl, Natasha B Producer: 20190903 In: Lung cancer (Amsterdam, Netherlands) vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	275.	Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. [electronic resource] by Kwak, Eunice L Shapiro, Geoffrey I Cohen, Seth M Becerra, Carlos R Lenz, Heinz-Josef Cheng, Wen-Fang Su, Wu-Chou Robohn, Meghan Le Maulf, Florence Lobmeyer, Maximilian T Chand, Vikram K Iafrate, A John Producer: 20140225 In: Cancer vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	276.	Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. [electronic resource] by Jorge, S E D C Kobayashi, S S Costa, D B Producer: 20150702 In: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas vol. 47 Availability: No items available. Save to lists Add to cart (remove)
	277.	Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption. [electronic resource] by Kikuchi, Katsuko Nozawa, Keiko Yamazaki, Naoya Nakai, Yasuo Higashiyama, Ayaka Asano, Masayuki Fujiwara, Yutaka Kanda, Shintaro Ohe, Yuichiro Takashima, Atsuo Boku, Narikazu Inoue, Akira Takahashi, Masanobu Mori, Takahiro Taguchi, Osamu Inoue, Yasuhiro Mizutani, Hitoshi Producer: 20190507 In: The Journal of dermatology vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	278.	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations. [electronic resource] by Liang, Sheng-Kai Ko, Jen-Chung Yang, James Chih-Hsin Shih, Jin-Yuan Producer: 20200305 In: Lung cancer (Amsterdam, Netherlands) vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	279.	Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease. [electronic resource] by Hoffknecht, Petra Tufman, Amanda Wehler, Thomas Pelzer, Theo Wiewrodt, Rainer Schütz, Martin Serke, Monika Stöhlmacher-Williams, Jan Märten, Angela Maria Huber, Rudolf Dickgreber, Nicolas J Producer: 20151030 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	280.	A gene expression profile indicative of early stage HER2 targeted therapy response. [electronic resource] by O'Neill, Fiona Madden, Stephen F Clynes, Martin Crown, John Doolan, Padraig Aherne, Sinéad T O'Connor, Robert Producer: 20131105 In: Molecular cancer vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 719 results.